Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP656816.RA7vnWFOkL5GWWwxYrftdWJEHkENL4MpLJqOWks_-3m1A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP656816.RA7vnWFOkL5GWWwxYrftdWJEHkENL4MpLJqOWks_-3m1A130_assertion type Assertion NP656816.RA7vnWFOkL5GWWwxYrftdWJEHkENL4MpLJqOWks_-3m1A130_head.
- NP656816.RA7vnWFOkL5GWWwxYrftdWJEHkENL4MpLJqOWks_-3m1A130_assertion description "[We investigated the effect of single-nucleotide polymorphisms (SNPs) spanning 10 methotrexate (MTX) pathway genes, namely AMPD1, ATIC, DHFR, FPGS, GGH, ITPA, MTHFD1, SHMT1, SLC19A1 (RFC) and TYMS on the outcome of MTX treatment in a UK rheumatoid arthritis (RA) patient cohort.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP656816.RA7vnWFOkL5GWWwxYrftdWJEHkENL4MpLJqOWks_-3m1A130_provenance.
- NP656816.RA7vnWFOkL5GWWwxYrftdWJEHkENL4MpLJqOWks_-3m1A130_assertion evidence source_evidence_literature NP656816.RA7vnWFOkL5GWWwxYrftdWJEHkENL4MpLJqOWks_-3m1A130_provenance.
- NP656816.RA7vnWFOkL5GWWwxYrftdWJEHkENL4MpLJqOWks_-3m1A130_assertion SIO_000772 22450926 NP656816.RA7vnWFOkL5GWWwxYrftdWJEHkENL4MpLJqOWks_-3m1A130_provenance.
- NP656816.RA7vnWFOkL5GWWwxYrftdWJEHkENL4MpLJqOWks_-3m1A130_assertion wasDerivedFrom befree-20140225 NP656816.RA7vnWFOkL5GWWwxYrftdWJEHkENL4MpLJqOWks_-3m1A130_provenance.
- NP656816.RA7vnWFOkL5GWWwxYrftdWJEHkENL4MpLJqOWks_-3m1A130_assertion wasGeneratedBy ECO_0000203 NP656816.RA7vnWFOkL5GWWwxYrftdWJEHkENL4MpLJqOWks_-3m1A130_provenance.